221 related articles for article (PubMed ID: 24626867)
21. Public health. The pertussis paradox.
Allen A
Science; 2013 Aug; 341(6145):454-5. PubMed ID: 23908204
[No Abstract] [Full Text] [Related]
22. Bordetella Pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance.
Dorji D; Mooi F; Yantorno O; Deora R; Graham RM; Mukkur TK
Med Microbiol Immunol; 2018 Feb; 207(1):3-26. PubMed ID: 29164393
[TBL] [Abstract][Full Text] [Related]
23. The control of pertussis--2007 and beyond.
Halperin SA
N Engl J Med; 2007 Jan; 356(2):110-3. PubMed ID: 17215528
[No Abstract] [Full Text] [Related]
24. Pertussis: pertussis control strategies and the options for improving current vaccines.
Plotkin SA
Expert Rev Vaccines; 2014 Sep; 13(9):1071-2. PubMed ID: 25090359
[TBL] [Abstract][Full Text] [Related]
25. Live Attenuated Pertussis Vaccine BPZE1 Protects Baboons Against Bordetella pertussis Disease and Infection.
Locht C; Papin JF; Lecher S; Debrie AS; Thalen M; Solovay K; Rubin K; Mielcarek N
J Infect Dis; 2017 Jul; 216(1):117-124. PubMed ID: 28535276
[TBL] [Abstract][Full Text] [Related]
26. Clinical evaluation of pertussis vaccines: US Food and Drug Administration regulatory considerations.
Farizo KM; Burns DL; Finn TM; Gruber MF; Pratt RD
J Infect Dis; 2014 Apr; 209 Suppl 1():S28-31. PubMed ID: 24626869
[TBL] [Abstract][Full Text] [Related]
27. The role of B. pertussis vaccine antigen gene variants in pertussis resurgence and possible consequences for vaccine development.
Preston A
Hum Vaccin Immunother; 2016 May; 12(5):1274-6. PubMed ID: 26889694
[TBL] [Abstract][Full Text] [Related]
28. Construction and evaluation of Bordetella pertussis live attenuated vaccine strain BPZE1 producing Fim3.
Debrie AS; Coutte L; Raze D; Mooi F; Alexander F; Gorringe A; Mielcarek N; Locht C
Vaccine; 2018 Mar; 36(11):1345-1352. PubMed ID: 29433898
[TBL] [Abstract][Full Text] [Related]
29. [Experimental whooping cough of nonhuman primate].
Kubrava DT; Medkova AIu; Siniashina LN; Shevtsova ZV; Matua AZ; Kondzharia IG; Barkaia VS; Elistratova ZhV; Karataev GI; Mikvabia ZIa; Gintsburg AL
Vestn Ross Akad Med Nauk; 2013; (8):28-33. PubMed ID: 24340642
[TBL] [Abstract][Full Text] [Related]
30. Mouse and pig models for studies of natural and vaccine-induced immunity to Bordetella pertussis.
Mills KH; Gerdts V
J Infect Dis; 2014 Apr; 209 Suppl 1():S16-9. PubMed ID: 24626866
[TBL] [Abstract][Full Text] [Related]
31. What to do about pertussis vaccines? Linking what we know about pertussis vaccine effectiveness, immunology and disease transmission to create a better vaccine.
Bolotin S; Harvill ET; Crowcroft NS
Pathog Dis; 2015 Nov; 73(8):ftv057. PubMed ID: 26253079
[TBL] [Abstract][Full Text] [Related]
32. Maternal and neonatal vaccination protects newborn baboons from pertussis infection.
Warfel JM; Papin JF; Wolf RF; Zimmerman LI; Merkel TJ
J Infect Dis; 2014 Aug; 210(4):604-10. PubMed ID: 24526741
[TBL] [Abstract][Full Text] [Related]
33. Pertussis outbreaks and pertussis vaccines: new insights, new concerns, new recommendations?
Poland GA
Vaccine; 2012 Nov; 30(49):6957-9. PubMed ID: 23141958
[No Abstract] [Full Text] [Related]
34. As immunity wanes, whooping cough returns.
Chin TL
Health Aff (Millwood); 2014 Dec; 33(12):2095-8. PubMed ID: 25489026
[No Abstract] [Full Text] [Related]
35. Bordetella pertussis: why is it still circulating?
Guiso N
J Infect; 2014 Jan; 68 Suppl 1():S119-24. PubMed ID: 24103807
[TBL] [Abstract][Full Text] [Related]
36. Functional Programming of Innate Immune Cells in Response to Bordetella pertussis Infection and Vaccination.
Gillard J; van Schuppen E; Diavatopoulos DA
Adv Exp Med Biol; 2019; 1183():53-80. PubMed ID: 31432398
[TBL] [Abstract][Full Text] [Related]
37. Bordetella pertussis pathogenesis: current and future challenges.
Melvin JA; Scheller EV; Miller JF; Cotter PA
Nat Rev Microbiol; 2014 Apr; 12(4):274-88. PubMed ID: 24608338
[TBL] [Abstract][Full Text] [Related]
38. Human Immune Responses to Pertussis Vaccines.
Ausiello CM; Mascart F; Corbière V; Fedele G
Adv Exp Med Biol; 2019; 1183():99-113. PubMed ID: 31342460
[TBL] [Abstract][Full Text] [Related]
39. Pertussis vaccines: state-of-the-art and future trends.
Tefon BE; Özcengiz E; Özcengiz G
Curr Top Med Chem; 2013; 13(20):2581-96. PubMed ID: 24066885
[TBL] [Abstract][Full Text] [Related]
40. Development of vaccines against pertussis caused by Bordetella holmesii using a mouse intranasal challenge model.
Saito M; Odanaka K; Otsuka N; Kamachi K; Watanabe M
Microbiol Immunol; 2016 Sep; 60(9):599-608. PubMed ID: 27515393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
